Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2005 1
2006 3
2009 1
2010 1
2011 4
2012 3
2013 3
2014 2
2015 1
2016 3
2017 5
2018 1
2019 4
2020 3
2021 5
2022 8
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. Among authors: jovanovic i. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease.
Dukić M, Radonjić T, Jovanović I, Zdravković M, Todorović Z, Kraišnik N, Aranđelović B, Mandić O, Popadić V, Nikolić N, Klašnja S, Manojlović A, Divac A, Gačić J, Brajković M, Oprić S, Popović M, Branković M. Dukić M, et al. Among authors: jovanovic i. Int J Mol Sci. 2023 Feb 13;24(4):3735. doi: 10.3390/ijms24043735. Int J Mol Sci. 2023. PMID: 36835145 Free PMC article. Review.
Aging of Liver in Its Different Diseases.
Radonjić T, Dukić M, Jovanović I, Zdravković M, Mandić O, Popadić V, Popović M, Nikolić N, Klašnja S, Divac A, Todorović Z, Branković M. Radonjić T, et al. Among authors: jovanovic i. Int J Mol Sci. 2022 Oct 28;23(21):13085. doi: 10.3390/ijms232113085. Int J Mol Sci. 2022. PMID: 36361873 Free PMC article. Review.
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial.
Danese S, Panaccione R, Feagan BG, Afzali A, Rubin DT, Sands BE, Reinisch W, Panés J, Sahoo A, Terry NA, Chan D, Han C, Frustaci ME, Yang Z, Sandborn WJ, Hisamatsu T, Andrews JM, D'Haens GR; GALAXI-1 Study Group. Danese S, et al. Lancet Gastroenterol Hepatol. 2024 Feb;9(2):133-146. doi: 10.1016/S2468-1253(23)00318-7. Epub 2023 Dec 14. Lancet Gastroenterol Hepatol. 2024. PMID: 38104569 Clinical Trial.
Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis.
Branković M, Jovanović I, Dukić M, Radonjić T, Oprić S, Klašnja S, Zdravković M. Branković M, et al. Among authors: jovanovic i. Int J Mol Sci. 2022 May 5;23(9):5146. doi: 10.3390/ijms23095146. Int J Mol Sci. 2022. PMID: 35563534 Free PMC article. Review.
Elevated Transaminases as Predictors of COVID-19 Pneumonia Severity.
Radonjić T, Milićević O, Jovanović I, Zdravković M, Dukić M, Mandić OM, Bjekić-Macut J, Marković OB, Todorović Z, Brajković M, Nikolić N, Klašnja S, Popadić V, Divac A, Marinković M, Alhayek N, Branković MS. Radonjić T, et al. Among authors: jovanovic i. Medicina (Kaunas). 2022 Jun 23;58(7):842. doi: 10.3390/medicina58070842. Medicina (Kaunas). 2022. PMID: 35888561 Free PMC article.
54 results